Ter0b 0000 01
Varubi Tablet
Product Images NDC 70720-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Varubi (NDC 70720-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Tersera Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ter0b 0000 02
Not available.*
Ter0b 0000 03
Ter0b 0000 04
Ter0b 0000 05
Ter0b 0000 06
VARUBI (rolapitant) is a prescription medicine available in tablet form. The package contains two 90 mg tablets, which is equivalent to a single dose of 180 mg. VARUBI is used in adults undergoing chemotherapy to prevent nausea and vomiting. This package is child-proof and should be kept out of children's reach. The drug should be stored at a temperature between 20 and 25°C, with short excursions permitted to 15°C - 30°C. For more information on correct dosage, refer to the package insert.*
Ter0b 0000 07
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
